During TRAIL treatment we observed that resistant tumor cell lines, such as RKO, responded to the apoptotic stimulus at early stages of TRAIL treatment, but at later times of exposure (24h and later) the apoptotic response defined by PARP cleavage was lost, despite continued exposure to TRAIL (Fig. 3). The gene discussed is TNFSF10; the disease is neoplasm.